Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Equity Bottom-Up

<ul>
<li>In this insight, we discuss 10 small cap cosmetic stocks in Korea, which are up on average 26.6% YTD, outperforming KOSPI which is up 10.9% YTD. </li>
<li>The drivers of their strong share price performances include reopening after the COVID-19 pandemic and ending of nearly all pandemic related restrictions (including wearing of face masks).</li>
<li>Among the 10 companies, we would focus on the top five small cap cosmetics stocks with the highest growth in operating profit in 1Q 2023 including Cosmecca Korea and Clio.</li>
</ul>


In this insight, we discuss 10 small cap cosmetic stocks in Korea, which are up on average 26.6% YTD, outperforming KOSPI which is up 10.9% YTD. 
The drivers of their strong share price performances include reopening after the COVID-19 pandemic and ending of nearly all pandemic related restrictions (including wearing of face masks).
Among the 10 companies, we would focus on the top five small cap cosmetics stocks with the highest growth in operating profit in 1Q 2023 including Cosmecca Korea and Clio.


Focus on 5 Korean Small Cap, Cosmetics Stocks With Significant Growth in Operating Profit in 1Q 2023

Event-Driven

<ul>
<li>On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&amp;C International.</li>
<li>Canaria Bio was designated as "administrative issue" and "investment attention issue" on 22 March 2024, which resulted in KRX deciding to remove this stock from KOSDAQ 150 on 26 March.</li>
<li>We believe that this inclusion of C&amp;C International in KOSDAQ 150 is likely to further positively impact its share price.</li>
</ul>


On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&amp;C International.
Canaria Bio was designated as "administrative issue" and "investment attention issue" on 22 March 2024, which resulted in KRX deciding to remove this stock from KOSDAQ 150 on 26 March.
We believe that this inclusion of C&amp;C International in KOSDAQ 150 is likely to further positively impact its share price.


Special Changes in KOSDAQ 150: Deletion (CanariaBio) + Addition  (C&C International)

<ul>
<li>In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024.</li>
<li>The following companies are likely candidates to be included in KOSDAQ150 rebalance in June 2024, including LS Materials, Gigavis, and Cafe24 Corp. </li>
<li>We also provide a list of 10 companies that are potential exclusion candidates from KOSDAQ150 rebalance in June 2024.</li>
</ul>


In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024.
The following companies are likely candidates to be included in KOSDAQ150 rebalance in June 2024, including LS Materials, Gigavis, and Cafe24 Corp. 
We also provide a list of 10 companies that are potential exclusion candidates from KOSDAQ150 rebalance in June 2024.


An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

Equity Capital Markets

<ul>
<li>APR is getting ready to complete an IPO in KOSPI in February 2024. The IPO price range is from 147,000 won to 200,000 won. </li>
<li>According to the bankers' valuation, the company's valuation is expected to range from 1.1 trillion won to 1.6 trillion won post IPO. </li>
<li>The company's best selling product is its skin care beauty device product called Medicube Age-R. </li>
</ul>


APR is getting ready to complete an IPO in KOSPI in February 2024. The IPO price range is from 147,000 won to 200,000 won. 
According to the bankers' valuation, the company's valuation is expected to range from 1.1 trillion won to 1.6 trillion won post IPO. 
The company's best selling product is its skin care beauty device product called Medicube Age-R. 


Global Healthcare Analyst

Tina Banerjee

<ul>
<li>
<a href="https://www.smartkarma.com/entities/cosmecca-korea" target="_blank" data-smartkarma-citation="entities:23616:1" rel="noopener">Cosmecca Korea (241710 KS)</a> clocked revenue of KRW115.7B (up 15% YoY) and operating profit of KRW11.2B (up 265% YoY) in Q223. Operating profit margin expanded 670bps YoY to 9.7%.</li>
<li>Cosmecca is a key beneficiary of the increasing global demand for the affordable indie cosmetics brands. These brands are now outpacing the overall beauty and personal care industry.</li>
<li>Since reporting strong Q1 result in May, Cosmecca Korea shares are on fire. Cosmecca is expected to continue its growth momentum due to strong global demand for affordable cosmetics.</li>
</ul>



Cosmecca Korea (241710 KS) clocked revenue of KRW115.7B (up 15% YoY) and operating profit of KRW11.2B (up 265% YoY) in Q223. Operating profit margin expanded 670bps YoY to 9.7%.
Cosmecca is a key beneficiary of the increasing global demand for the affordable indie cosmetics brands. These brands are now outpacing the overall beauty and personal care industry.
Since reporting strong Q1 result in May, Cosmecca Korea shares are on fire. Cosmecca is expected to continue its growth momentum due to strong global demand for affordable cosmetics.


Cosmecca Korea (241710 KS): Strong 2Q23 Result; Favorable Industry Tailwind to Enhance the Glow

South Korea

Clio Cosmetics Co., Ltd. manufactures and markets lines of skin care and make-up products.  The Company owns multiple brands including Club Clio Professional, Peripera, and Goodal.

Clio Cosmetics (237880 KS)

Focus on 5 Korean Small Cap, Cosmetics Stocks With Significant Growth in Operating Profit in 1Q 2023

We would focus on the top five Korean small cap cosmetics stocks with the highest growth in operating profit in 1Q 2023 including Cosmecca Korea...

Douglas Kim

Special Changes in KOSDAQ 150: Deletion (CanariaBio) + Addition (C&C International)

On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&C...

Douglas Kim

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...

Douglas Kim

APR IPO Preview

APR is getting ready to complete an IPO in KOSPI in February 2024. According to the bankers' valuation, the company's valuation is expected to...

Douglas Kim

Cosmecca Korea (241710 KS): Strong 2Q23 Result; Favorable Industry Tailwind to Enhance the Glow

Cosmecca Korea reports strong Q2 results, with revenue up 15% YoY and operating profit up 265% YoY. The company benefits from the growing demand...

Tina Banerjee

Focus on 5 Korean Small Cap, Cosmetics Stocks With Significant Growth in Operating Profit in 1Q 2023

We would focus on the top five Korean small cap cosmetics stocks with the highest growth in operating profit in 1Q 2023 including Cosmecca Korea...

Douglas Kim

Special Changes in KOSDAQ 150: Deletion (CanariaBio) + Addition (C&C International)

On 22 March, the Korea Exchange announced special changes to KOSDAQ 150. CanariaBio will be excluded from KOSDAQ 150 and it will be replaced by C&C...

Douglas Kim

An Early Look at the Potential KOSDAQ150 Rebalance Candidates in June 2024

In this insight, we discuss the potential KOSDAQ150 rebalance candidates in June 2024. Potential inclusion candidates include LS Materials,...

Douglas Kim

APR IPO Preview

APR is getting ready to complete an IPO in KOSPI in February 2024. According to the bankers' valuation, the company's valuation is expected to...

Douglas Kim

Cosmecca Korea (241710 KS): Strong 2Q23 Result; Favorable Industry Tailwind to Enhance the Glow

​Cosmecca Korea reports strong Q2 results, with revenue up 15% YoY and operating profit up 265% YoY. The company benefits from the growing demand...

Tina Banerjee

Cosmecca Korea reports strong Q2 results, with revenue up 15% YoY and operating profit up 265% YoY. The company benefits from the growing demand...